194700 — Novarex Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapContrarian

Annual cashflow statement for Novarex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	17,015	26,801	30,648	24,245	26,142
Depreciation
Amortisation
Non-Cash Items	1,412	2,457	1,911	3,882	1,867
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-22,456	-16,616	-14,217	-15,775	-11,161
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-1,300	16,260	24,130	20,107	25,302
Capital Expenditures	-21,197	-40,491	-37,398	-16,119	-8,718
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,205	-5,495	3,339	-7,233	12,190
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-22,402	-45,986	-34,059	-23,352	3,472
Financing Cash Flow Items	-139	—	—	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	17,636	32,622	-2,889	11,178	-25,257
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-6,072	2,337	-12,691	7,851	3,215